Use Able AI chat for product recommendations
  • Featured Product
  • KD/KO Validated

ARRDC3 Polyclonal antibody, PBS Only

ARRDC3 Polyclonal Antibody for WB, ELISA

Cat No. 25060-1-PBS
Review Product
Download datasheet

Host / Isotype

Rabbit / IgG

Reactivity

human

Applications

WB, ELISA

arrestin domain containing 3, Arrestin domain-containing protein 3, TBP-2-like inducible membrane protein, TLIMP

Formulation:  PBS Only
Conjugate:  Unconjugated
Size/Concentration: 
SKU: 

-/ -

Freight/Packing: -

Quantity

Please visit your regions distributor:

Able AI
Able AI
What's the best dilution for ARRDC3 in ?

Product Information

25060-1-PBS targets ARRDC3 in WB, ELISA applications and shows reactivity with human samples.

Tested Reactivity human
Host / Isotype Rabbit / IgG
Class Polyclonal
Type Antibody
Immunogen

CatNo: Ag18717

Product name: Recombinant human ARRDC3 protein

Source: e coli.-derived, PGEX-4T

Tag: GST

Domain: 14-122 aa of BC053619

Sequence: DCLNDSNVPVYSSGDTVSGRVNLEVTGEIRVKSLKIHARGHAKVRWTESRNAGSNTAYTQNYTEEVEYFNHKDILIGHERDDDNSEEGFHTIHSGRHEYAFSFELPQTP

Predict reactive species
Full Name arrestin domain containing 3
Calculated Molecular Weight 414 aa, 46 kDa
Observed Molecular Weight 46 kDa
GenBank Accession NumberBC053619
Gene Symbol ARRDC3
Gene ID (NCBI) 57561
RRIDAB_2879878
Conjugate Unconjugated
FormLiquid
Purification MethodAntigen affinity purification
UNIPROT IDQ96B67
Storage Buffer PBS only, pH 7.3.
Storage ConditionsStore at -80°C.

Background Information

ARRDC3 (Arrestin domain-containing protein 3) is an adaptor protein involved in modulating the cell-surface abundance of adrenergic receptors and likely other G protein-coupled receptors. It participates in NEDD4-dependent ubiquitination, endocytosis, and subsequent degradation of activated ADRB2. ARRDC3 may recruit NEDD4 to ADRB2; alternatively, it may act as an adaptor that contributes to endosomal targeting of ADRB2 rather than serving as a primary mediator for NEDD4 recruitment to this receptor (PMID: 20559325; 21982743; 23208550).

Loading...
||
New chat

Able®

正在加载,请稍候...